Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study

on behalf of the G-ROP Study Group

Research output: Contribution to journalArticle

Abstract

Importance: The Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study showed that the addition of postnatal weight gain to birth weight and gestational age detects similar numbers of infants with ROP, but requires examination of fewer infants. Objective: To determine the incremental cost-effectiveness of screening with G-ROP compared with conventional screening. Design, setting and participants: We built a microsimulation model of a 1-year US birth cohort <32 weeks gestation, using data from the G-ROP study. We obtained resource utilization estimates from the G-ROP dataset and from secondary sources, and test characteristics from the G-ROP cohort. Results: Among 78,281 infants nationally, screening with G-ROP detected ~25 additional infants with Type 1 ROP. This was accomplished with 36,233 fewer examinations, in 14,073 fewer infants, with annual cost savings of approximately US$2,931,980 through hospital discharge. Conclusions: Screening with G-ROP reduced costs while increasing the detection of ROP compared with current screening guidelines.

Original languageEnglish (US)
Pages (from-to)1100-1108
Number of pages9
JournalJournal of Perinatology
Volume40
Issue number7
DOIs
StatePublished - Jul 1 2020

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study'. Together they form a unique fingerprint.

  • Cite this